Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
Obesity continues to exist around the world despite the risk to health and death from illness and disease.
Read Full NewsThis rheumatology month in review emphasizes new data and impactful approvals.
The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.
A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.
The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.
Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.
The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.
The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.
1.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
2.
Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer
3.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
4.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
5.
Oral drug combination extends progression-free survival in advanced ER-positive breast cancer
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
The importance of understanding normal serum osmolality
3.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
4.
Tazemetostat: A Promising New Treatment for Cancer
5.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge